Katherine P Liao Selected Research

Tumor Necrosis Factor Inhibitors

6/2021	Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial.
1/2021	Validation of a Bioassay for Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis.
1/2020	Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score-Matched Cohort Study.
8/2019	Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis.
1/2018	The Association Between Arthralgia and Vedolizumab Using Natural Language Processing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katherine P Liao Research Topics

Disease

32	Rheumatoid Arthritis 11/2021 - 03/2009
9	Inflammation (Inflammations) 10/2021 - 10/2013
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 08/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 11/2015
4	Genetic Risk Score 11/2021 - 01/2011
3	Hyperlipidemias (Hyperlipidemia) 10/2018 - 04/2015
3	Crohn Disease (Crohn's Disease) 04/2016 - 08/2013
3	Ulcerative Colitis 04/2016 - 08/2013
2	Neoplasms (Cancer) 09/2021 - 05/2014
2	Chondrocalcinosis (Pseudogout) 01/2021 - 06/2018
2	Arthritis (Polyarthritis) 02/2020 - 11/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 05/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Sickle Cell Trait 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021
1	Peripheral Arterial Disease 10/2021
1	Arteritis 06/2021
1	Sudden Infant Death (SID) 01/2021
1	Synovitis 01/2021
1	Ankylosing Spondylitis 01/2020
1	Infections 01/2020
1	Sacroiliitis 01/2020
1	Spondylitis 01/2020
1	Non-Radiographic Axial Spondyloarthritis 11/2019
1	Insulin Resistance 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Atherosclerosis 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Obesity 01/2017
1	Hypertension (High Blood Pressure) 05/2016
1	Diabetes Mellitus 01/2016
1	Sclerosing Cholangitis 01/2016
1	Dyslipidemias (Dyslipidemia) 11/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2015
1	Heart Diseases (Heart Disease) 10/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2009

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 01/2021 - 12/2013
9	LDL CholesterolIBA 01/2021 - 06/2014
6	Antirheumatic Agents (DMARD)IBA 06/2021 - 02/2015
6	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 06/2014
5	Tumor Necrosis Factor InhibitorsIBA 06/2021 - 01/2018
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2015
4	oxidized low density lipoproteinIBA 10/2018 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2019
3	C-Reactive ProteinIBA 10/2021 - 01/2017
3	Biological ProductsIBA 01/2020 - 01/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016 - 01/2016
3	Vitamin D FDA LinkGeneric 11/2015 - 08/2013
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 11/2021 - 05/2016
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2021 - 01/2018
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 08/2019
2	Calcium PyrophosphateIBA 01/2021 - 06/2018
2	Infliximab (Remicade)FDA Link 01/2020 - 04/2016
2	Adalimumab (Humira)FDA Link 01/2020 - 04/2016
2	CholesterolIBA 01/2018 - 11/2015
2	AntibodiesIBA 01/2018 - 03/2015
2	Fibrinogen (Factor I)FDA Link 01/2018 - 01/2017
2	HDL LipoproteinsIBA 01/2017 - 01/2015
2	AutoantibodiesIBA 01/2017 - 03/2013
2	Antihypertensive Agents (Antihypertensives)IBA 05/2016 - 01/2016
2	SteroidsIBA 04/2016 - 10/2013
2	Monoclonal AntibodiesIBA 04/2016 - 01/2016
2	HDL CholesterolIBA 11/2015 - 01/2015
2	Lipoproteins (Lipoprotein)IBA 01/2015 - 12/2013
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2013
2	hydroxide ionIBA 05/2014 - 08/2013
1	P-2 (P 2)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 09/2021
1	Immunologic Factors (Immunomodulators)IBA 06/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Troponin T (Troponin T1)IBA 01/2021
1	Biosimilar PharmaceuticalsIBA 02/2020
1	Etanercept (Enbrel)FDA Link 01/2020
1	Abatacept (Orencia)FDA Link 01/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 08/2019
1	Janus Kinase InhibitorsIBA 01/2018
1	CytokinesIBA 01/2018
1	vedolizumabIBA 01/2018
1	serum P-component (CIt)IBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2017
1	AntigensIBA 01/2017
1	EpitopesIBA 01/2017
1	Leflunomide (Arava)FDA LinkGeneric 05/2016
1	Prednisone (Sone)FDA LinkGeneric 04/2016
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2015
1	Peptides (Polypeptides)IBA 03/2015
1	Anti-Citrullinated Protein AntibodiesIBA 03/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	GoldIBA 07/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2011
1	cyclic citrullinated peptideIBA 03/2009

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2013
1	Colectomy 01/2022
1	Immunotherapy 09/2021